Syngene International Limited Total Liabilities
Syngene International Limited total liabilities. Based on the latest financial reports, Syngene International Limited (SYNGENE) has total liabilities worth Rs18.07 Billion INR (≈ $195.44 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Syngene International Limited to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Syngene International Limited (2010–2025)
Total liabilities of Syngene International Limited from 2010 to 2025. This chart illustrates how Syngene International Limited's total liabilities have evolved over time, based on quarterly financial data. Explore Syngene International Limited long-term investment allocation to see how much of total assets are deployed in long-term investments.
Syngene International Limited Competitors by Total Liabilities
The table below lists competitors of Syngene International Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sonos Inc
NASDAQ:SONO
|
USA | $455.12 Million |
|
SJW Group Common Stock
NYSE:SJW
|
USA | $3.33 Billion |
|
Zhuzhou CRRC Times Electric Co. Ltd
F:ZTX
|
Germany | €25.17 Billion |
|
NCC AB (publ)
ST:NCC-B
|
Sweden | Skr25.25 Billion |
|
Nayax Ltd
NASDAQ:NYAX
|
USA | $428.24 Million |
|
Genting Malaysia Bhd
KLSE:4715
|
Malaysia | RM19.44 Billion |
|
Sanxiang Advanced Materials
SHG:603663
|
China | CN¥743.18 Million |
|
Innovex International, Inc
NYSE:INVX
|
USA | $256.77 Million |
Liability Composition Analysis (2010–2025)
This chart breaks down Syngene International Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Syngene International Limited's balance sheet.
Liquidity & Leverage Metrics
Syngene International Limited Total Liabilities Ratios Explained
Syngene International Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.72 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.27 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.38 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Syngene International Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Syngene International Limited (2010–2025)
The table below shows the annual total liabilities of Syngene International Limited from 2010 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs20.69 Billion ≈ $223.77 Million |
+9.26% |
| 2024-03-31 | Rs18.94 Billion ≈ $204.81 Million |
-14.42% |
| 2023-03-31 | Rs22.13 Billion ≈ $239.33 Million |
-2.35% |
| 2022-03-31 | Rs22.66 Billion ≈ $245.08 Million |
+9.91% |
| 2021-03-31 | Rs20.62 Billion ≈ $222.98 Million |
+3.76% |
| 2020-03-31 | Rs19.87 Billion ≈ $214.90 Million |
+14.52% |
| 2019-03-31 | Rs17.35 Billion ≈ $187.64 Million |
+18.15% |
| 2018-03-31 | Rs14.69 Billion ≈ $158.82 Million |
+7.93% |
| 2017-03-31 | Rs13.61 Billion ≈ $147.15 Million |
+1.80% |
| 2016-03-31 | Rs13.37 Billion ≈ $144.56 Million |
+131.82% |
| 2015-03-31 | Rs5.77 Billion ≈ $62.36 Million |
+8.47% |
| 2014-03-31 | Rs5.32 Billion ≈ $57.49 Million |
+158.56% |
| 2013-03-31 | Rs2.06 Billion ≈ $22.23 Million |
-29.05% |
| 2012-03-31 | Rs2.90 Billion ≈ $31.34 Million |
+2.26% |
| 2011-03-31 | Rs2.83 Billion ≈ $30.65 Million |
-11.02% |
| 2010-03-31 | Rs3.19 Billion ≈ $34.44 Million |
-- |
About Syngene International Limited
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and anal… Read more